| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 2.14 MB | Adobe PDF |
Authors
Abstract(s)
Este trabalho apresenta-se em dois capítulos, o projeto de investigação intitulado
“Produtos cutâneos para a dermatite atópica: Preferências dos utilizadores
relativamente a formulações cosméticas/farmacêuticas e impacto no seguimento da
terapêutica” e o “Relatório de estágio em farmácia comunitária”, os quais são parte
integrante da unidade curricular “estágio” do Mestrado Integrado em Ciências
Farmacêuticas.
A dermatite atópica é uma doença inflamatória crónica da pele que afeta todas as faixas
etárias e etnias e que tem tido uma prevalência elevada, especialmente em crianças, ao
longo dos últimos anos. A procura de estratégias de promoção da qualidade de vida
destes utentes é, por esse motivo, um assunto de elevado interesse. Na primeira parte
deste trabalho foi desenvolvido e aplicado um questionário com o propósito de recolher
informações dos utentes com dermatite atópica (ou dos seus cuidadores)
relativamente à aceitabilidade e preferências quanto a produtos de aplicação cutânea
estudando, particularmente, os inconvenientes identificados e avaliando de que
forma afetam a adesão à terapêutica e qualidade de vida dos utentes.
Neste estudo foram validadas 114 respostas, das quais 101 correspondem a indivíduos
que possuem DA e 13 são cuidadores de indivíduos que possuem DA, com idades
principalmente compreendidas entre os 20-24 anos (22,7%) e os 25-29 anos (22,7%). A
sua grande maioria relata que o prurido é o sintoma mais incomodativo (92,1%)
seguido pelo eritema (83,3%), para manuseamento das exacerbações da DA a maioria
relata fazer uso de produtos cosméticos (de limpeza e hidratantes) (90,4%) e afirma
que afetam de forma impactante na sua qualidade vida (57%). No que concerne as
medidas tópicas farmacológicas estes reportam que fazem uso de corticoide tópicos
menos de uma vez por mês (41,1%).
Na sua maioria os inquiridos referem que um produto que seja pouco gorduroso, pouco
espesso e com a forma farmacêutica de creme (consistência aquosa, absorção
relativamente mais rápida quando comparada a uma pomada, quando aplicadas em
maior extensão) melhoraria a probabilidade de ser usado para a DA. Aspetos como cor,
fragância e quantidade de produto são indiferentes para os inquiridos. No que toca ao segundo capitulo deste trabalho, este relata os conhecimentos
adquiridos, as aptidões desenvolvidas e experiências vivenciadas no período
compreendido entre o dia 1 de fevereiro e o dia 17 se junho, no âmbito do estágio
curricular em farmácia comunitária. O meu estágio foi realizado na Farmácia Gomes
Pinho, pertencente ao concelho Arouca, com supervisão da Dra. Patrícia Pinto.
This document reports the activities performed to complete the degree in pharmaceutical sciences. The report is organized into two chapters: the research project on "Skin products for atopic dermatitis: User preferences regarding cosmetic/pharmaceutical formulations and impact on therapeutic follow-up" and the "Internship report in community pharmacy", which are part of the curricular unit "internship" of the Integrated Master's Degree in Pharmaceutical Sciences. Atopic dermatitis is a chronic inflammatory skin disease effecting all age groups and ethnicities and has shown an increasing prevalence in children over the last few years. Identifying strategies to improve these users quality of life is of utmost importance. In the first part of this study, a questionnaire was developed and applied collect information from users with atopic dermatitis (or their caregivers) regarding the acceptability of and preferences for skin care products. The purpose was to study the identified drawbacks and asses how they affect users therapeutic adherence and quality of life. In this study, 114 answers were validated, of which 101 correspond to individuals with AD and 13 are caregivers of individuals with AD, aged mainly between 20-24 years (22.7%) and 25-29 years (22.7%). The vast majority report that itching is the most bothersome symptom (92.1%) followed by erythema (83.3%). To manage these exacerbations of AD most report using cosmetic products (cleansers and moisturizers) (90.4%) and state that they impact their quality of life (57%). Regarding topical pharmacological measures, they report using topical corticosteroids less than once a month (41.1%). Most respondents report that a product that is low in fat, thin and in the pharmaceutical form of a cream (watery consistency, relatively faster absorption compared to an ointment when applied more widely) would improve the likelihood of being used for AD. Aspects such as color, fragrance and amount of product are indifferent to the respondents. The second chapter of this work, reports the knowledge acquired, the skills developed and the experiences acquired from February 1st to June 17th as part of my internship in community pharmacy. My internship was conducted in the Gomes Pinho Pharmacy, belonging to the municipality of Arouca, under the supervision of Dr. Patricia Pinto.
This document reports the activities performed to complete the degree in pharmaceutical sciences. The report is organized into two chapters: the research project on "Skin products for atopic dermatitis: User preferences regarding cosmetic/pharmaceutical formulations and impact on therapeutic follow-up" and the "Internship report in community pharmacy", which are part of the curricular unit "internship" of the Integrated Master's Degree in Pharmaceutical Sciences. Atopic dermatitis is a chronic inflammatory skin disease effecting all age groups and ethnicities and has shown an increasing prevalence in children over the last few years. Identifying strategies to improve these users quality of life is of utmost importance. In the first part of this study, a questionnaire was developed and applied collect information from users with atopic dermatitis (or their caregivers) regarding the acceptability of and preferences for skin care products. The purpose was to study the identified drawbacks and asses how they affect users therapeutic adherence and quality of life. In this study, 114 answers were validated, of which 101 correspond to individuals with AD and 13 are caregivers of individuals with AD, aged mainly between 20-24 years (22.7%) and 25-29 years (22.7%). The vast majority report that itching is the most bothersome symptom (92.1%) followed by erythema (83.3%). To manage these exacerbations of AD most report using cosmetic products (cleansers and moisturizers) (90.4%) and state that they impact their quality of life (57%). Regarding topical pharmacological measures, they report using topical corticosteroids less than once a month (41.1%). Most respondents report that a product that is low in fat, thin and in the pharmaceutical form of a cream (watery consistency, relatively faster absorption compared to an ointment when applied more widely) would improve the likelihood of being used for AD. Aspects such as color, fragrance and amount of product are indifferent to the respondents. The second chapter of this work, reports the knowledge acquired, the skills developed and the experiences acquired from February 1st to June 17th as part of my internship in community pharmacy. My internship was conducted in the Gomes Pinho Pharmacy, belonging to the municipality of Arouca, under the supervision of Dr. Patricia Pinto.
Description
Keywords
Aceitabilidade dos Produtos Tópicos Dermatite Atópica Preferências do Utilizador Produtos Cosméticos Produtos Cutâneos